Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…rs, Survival outcomes varied substantially across cancer types. Pancreatic cancer had the poorest prognosis, with a median survival of 4.1 months…
…symmetric funnel plot (Egger’s test; p=0.002). For incidence of prostate cancer meta RR was 1.16 (95% CI 0.99 to 1.37) while the RR for mortali…
…s were followed up until 31st December 2025.Patients with prior pancreatic cancer or pancreatitis were excluded. Continuous variables were summar…
…s, range 53–89, 10 males, 3 females). Underlying diagnoses were pancreatic cancer (10/13, 76.9%), distal cholangiocarcinoma (1/13, 7.7%), small b…
…ive to have a scalable, imaging-based method at hand to predict pancreatic cancer before the patient becomes symptomatic and before a lesion beco…
…irinotecan, oxaliplatin) chemotherapy for borderline resectable pancreatic adenocarcinoma. The patient presented with fever and raised C reactive protein…
…pproved by US Food and Drug Administration for the treatment of pancreatic cancers. Highly desmoplastic and immune-desert phenotypes of pancreatic…
…oups. In contrast, a sex-related difference was observed in the colorectal cancer subgroup. Women had lower API at the final evaluation than men,…
…rt selection. We identified 620 168 Veterans Affairs users with type 2 diabetes who used GLP-1RAs or sulfonylureas between 1 January 2017 and 3…
…cted a retrospective, multicentre cohort study in patients with pancreatic cancer (PC) or colorectal cancer (CRC) treated with UGT1A1 genotype-gu…
… structural damage, lifelong metabolic and functional sequelae, pancreatic cancer risk and poor quality of life. Against this backdrop, the repur…
…ceptability of the STRONG programme compared with usual care in pancreatic cancer surgery patients after hospital discharge (n = 80). The trial is design…